- Home
- SU vs TAK Comparison
SU vs TAK Comparison
Compare SU & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SU | TAK |
|---|---|---|
| Founded | 1917 | 1781 |
| Country | Canada | Japan |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.8B | 43.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SU | TAK |
|---|---|---|
| Price | $43.05 | $15.64 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 2.5M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.84% | 3.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.06 | 0.14 |
| Revenue | ★ $35,463,676,235.00 | $29,846,840,032.00 |
| Revenue This Year | $0.63 | N/A |
| Revenue Next Year | N/A | $0.47 |
| P/E Ratio | ★ $13.80 | $219.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.79 | $12.80 |
| 52 Week High | $45.60 | $15.69 |
Technical Indicators
Market Signals| Indicator | SU | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 78.41 |
| Support Level | $42.46 | $14.43 |
| Resistance Level | $43.36 | $14.66 |
| Average True Range (ATR) | 0.71 | 0.17 |
| MACD | -0.16 | 0.13 |
| Stochastic Oscillator | 37.50 | 99.66 |
Price Performance
Historical ComparisonAbout SU Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil production, petroleum refining in Canada and the U.S., and the company's Petro-Canada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, and renewable fuels. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power. The company's operating segments include Oil Sands, Exploration & Production, Refining & Marketing (R&M), and Corporate & eliminations. Geographically, the company generates a majority of its revenue from Canada.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.